The National Institutes of Health (NIH) has suspended all drug making practices and halted clinical trials using products made at its facility after federal regulators discovered some of the products were contaminated with fungus. Six patients who reportedly received the tainted meds are being watched for any adverse effects. “This is a distressing and unacceptable situation,” said NIH Director Dr. Francis Collins, who expressed concern for putting patients in “harms way because of a failure to follow standard operating procedures.” NIH is a biomedical research facility primarly located in Bethesda, Md. It is an agency of the U.S. Department of ... Read More
Righting Injustice is published by the Beasley Allen Law Firm. If you are interested in a free legal consultation, please take a few moments to fill out the contact form with as many details as possible. The more information you provide us, the better we can evaluate your claim.